中國疫情重來，新冠紅利助跑MRNA股價翻升

中國新一波 COVID-19 pandemic comes back，Moderna的 mRNA 疫苗很可能在2023下半年重新成為市場寵兒，MRNA股價@137.75 順風炒作再漲一波。疫情是人道災難，也是投資良機。YMYD

China braces for new Covid wave with up to 65 million weekly cases
https://www.cnbctv18.com/world/china-braces-for-new-covid-19-wave-with-up-to-65-million-weekly-cases-16728131.htm